Financial Data and Key Metrics Changes - In Q2 2025, the company reported quarterly revenue of RMB million, reflecting a year-over-year increase of 23.9% and a quarter-over-quarter increase of 11.2% [5][27] - Operating profit surged by 85.9% year-over-year, with operating margins improving by 3.9 percentage points [5][30] - Net profit attributable to ordinary shareholders reached RMB 140 million, up 58.7% year-over-year [30] Business Line Data and Key Metrics Changes - The insurance business saw first-year premiums reach RMB billion, up 80.2% year-over-year and 53.1% quarter-over-quarter [12] - Insurance-related revenue increased by 28.7% year-over-year [12] - The digital clinical trial solutions segment reported a revenue increase of 34.2% year-over-year, amounting to RMB 27.7 million [27] Market Data and Key Metrics Changes - The number of patients enrolled in the eFine platform reached a historical high, with nearly 1,000 patients enrolled in 2025 [6] - Cumulatively, around 480 million people donated RMB 70 billion to approximately 3,540,000 patients through the medical profiling platform [20] Company Strategy and Development Direction - The company is focused on integrating AI technology across its insurance and healthcare sectors to enhance operational efficiency and customer acquisition [5][9] - Plans to expand the use of AI in various business segments, including customer service and underwriting, are underway [9][31] - The company aims to continue enhancing its AI capabilities and operational efficiency to drive future growth [30] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the integration of AI leading to improved operational efficiency and customer acquisition [5][30] - The company is committed to creating long-term value for shareholders and society while optimizing operations for stable growth [31] Other Important Information - The Board approved a cash dividend of $10,900,000, representing a 50% increase over the previous dividend [10] - The company has repurchased approximately 55.7 million ADS for $109 million since the initiation of its share repurchase program in 2021 [11] Q&A Session Summary Question: What are the expectations for future growth in the insurance business? - Management highlighted that the insurance business is expected to continue its robust growth trajectory, driven by AI integration and enhanced customer acquisition strategies [12][14] Question: How is the company addressing operational costs? - The company noted that while operating costs increased by 18.7% year-over-year, the growth rate of costs was lower than that of revenue, indicating improved operational efficiency [28][30]